Clinical profile, prognosis and treatment of patients with infective endocarditis - A 14-year follow-up study

Polskie Archiwum Medycyny Wewnetrznej

Volumn 117, Issue 11-12, 2007, Pages 512-520

  Krecki, Radoslaw ^a   Drozdz, Jaroslaw ^a   Ibata, Georges ^a   Lipiec, Piotr ^a   Ostrowski, Stanislaw ^a   Kasprzak, Jaroslaw ^a   Krzeminska Pakula, Maria ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Endocarditis; Infection; Prognosis; Treatment

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE;

ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RHEUMATIC HEART DISEASE; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 38649134141     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Karchmer AW. Infective endocarditis. In: Morrow DA, Gersh BJ, Braunwald E. Chronic coronary hart disease in Braunwald's Heart Disease - a textbook of cardiovascular medicine. 7th edition. Philadelphia, Elsevier Saunders, 2005; 50: 3-118.
2. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005; 111: 394-434.
3. Netzer RO, Zollinger E, Seiler C, et al. Infective endocarditis: clinical spectrum, presentation and outcome. An analysis of 212 cases 1980-1995. Heart. 2000; 84: 25-30.
4. Bayer AS, Bolger AF, Taubert KA, et al. Diagnosis and management of infective endocarditis and its complications. Circulation. 1998; 98: 2936-2948.
5. Tleyjeh IM, Ghomrawi HMK, Steckelberg MJ, et al. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation. 2007; 115: 1721-1728.
6. Vikram HR, Buenconsejo J, Hasbun R, at al. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA. 2003; 290: 3207-3214.
7. Netzer RO, Altwegg SC, Zollinger E, et al. Infective endocarditis: determinants of long term outcome. Heart. 2002; 88: 61-66.
8. Wallace SM, Walton BI, Kharbanda RK, et al. Mortality from infective endocarditis: clinical predictors of outcome. Heart. 2002; 88: 53-60.
9. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. 1994; 89: 635-641.
10. Gohlke-Bärwolf C, Acar J, Oakley C, et al. Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 1995; 16: 1320-1330.
11. The Task Force on infective endocarditis of the European Society of Cardiology. Guidelines on prevention, diagnosis and treatment of infective endocarditis - executive summary. Eur Heart J. 2004; 25: 267-276.
12. Wołkanin-Bartnik J, Zieliński T, Pogorzelska H, et al. Powikłania zakrzepowo-zatorowe i krwotoczne u pacjentów po wszczepieniu sztucznej zastawki serca leczonych doustnymi lekami przeciwzakrzepowymi. Czynniki ryzyka zależne od jakości leczenia przeciwzakrzepowego. Pol Arch Med Wewn. 2005; 1: 673-681.
13. Dentali F, Douketis JD, Lim W, at al. Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials. Arch Intern Med. 2007; 167: 117-124.
14. Bauernschmitt R, Jakob HG, Vahl CF, et al. Operation for infective endocarditis: results after implantation of mechanical valves. Ann Thorac Surg. 1998; 65: 359-364.
15. Abramczuk E, Hryniewiecki T, Stȩpińska J. Effects of pathogenic factors on prognosis in patients with prosthetic valve endocarditis. Kardiol Pol. 2007; 65: 115-122.
16. Krzemińska-Pakuła M. Prosthetic valve endocarditis - prognosis and treatment. Kardiol Pol. 2007; 65: 123-124.
17. Abramczuk E, Hryniewiecki T, Stȩpińska J. Influence of pathogenetic factors on prognosis in patients with native valve infective endocarditis. Kardiol Pol. 2006; 64: 675-681.
18. Renzulli A, Carozza A, Marra C, et al. Are blood and valve cultures predictive for long-term outcome following surgery for infective endocarditis? Eur J Cardiothoracic Surg. 2000; 17: 228-233.
19. Naber CK, Erbel R. Diagnosis of culture negative endocarditis: novel strategies to prove the suspect guilty. Heart. 2003; 89: 241-243.
20. Peric M, Vuk F, Huskic R, et al. Active infective endocarditis: low mortality associated with early surgical treatment. Cardiovasc Surg. 2000; 8: 208-213.
21. Alexiou C, Langley SM, Stafford H, et al. Surgery for active culture-positive endocarditis: determinants of early and late outcome. Ann Thorac Surg. 2000; 69: 1448-1454.
22. Cabell CH, Abrutyn E, Fowler VG Jr, et al. International Collaboration on Endocarditis Merged Database (ICE-MD) Study Group Investigators. Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. Am Heart J. 2005; 150: 1092-1098.
23. Wang A, Pappas P, Anstrom KJ, et al. International Collaboration on Endocarditis Investigators. The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort. Am Heart J. 2005; 150: 1086-1091.
24. Tornos MP, Permanyer-Miralda G, Olona M, et al. Long-term complications of native valve infective endocarditis in non-addicts: a 15-year follow-up study. Ann Intern Med. 1992; 117: 567-572.
25. Malquarti V, Saradarian W, Etienne J, et al. Prognosis of native valve infective endocarditis: a review of 253 cases. Eur Heart J. 1984; 5: 11-20.
26. Castillo JC, Anguita MP, Ramirez A, et al. Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study. Heart. 2000; 83: 525-530.
27. Vlessis AA, Hovaguimian H, Jaggers J, et al. Infective endocarditis: ten-year review of medical and surgical therapy. Ann Thorac Surg. 1996; 61: 1217-1222.
28. Olaison L, Hogevik H, Myken P et al. Early surgery in infective endocarditis. QJM. 1996; 89: 267-278.
29. Croft CH, Woodward W, Elliott A, et al. Analysis of surgical versus medical therapy in active complicated native valve infective endocarditis. Am J Cardiol. 1983; 51: 1650-1655.
30. Yu VL, Fang GD, Keys TF, et al. Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only. Ann Thorac Surg. 1994; 58: 1073-1077.
31. Remadi JP, Habib G, Nadji G. Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis. Ann Thorac Surg. 2007; 83: 1295-1302.
32. Revilla A, Lopez J, Vilacosta I, et al. Clinical and prognostic profile of patients with infective endocarditis who need urgens surgery. Eur Heart J. 2007; 28: 65-71.
33. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, et al. The impact of valve surgery on 6-month in left-sided infective endocarditis. Circulation. 2007; 115: 1721-1728.